UK markets closed

Lyra Therapeutics, Inc. (LYRA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.3280-0.0036 (-1.09%)
At close: 04:00PM EDT
0.3300 +0.00 (+0.61%)
After hours: 07:53PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
22,353
32,550
45,747
74,593
-
Other short-term investments
80,400
65,344
0
-
-
Total cash
102,753
97,894
45,747
74,593
-
Net receivables
-
-
-
-
0
Other current assets
2,068
2,935
2,171
1,324
-
Total current assets
104,821
100,829
47,918
75,917
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
37,197
8,640
9,737
7,344
-
Accumulated depreciation
-1,921
-4,174
-3,879
-2,878
-
Net property, plant and equipment
35,276
4,466
5,858
4,466
-
Other long-term assets
2,503
4,673
1,091
447
-
Total non-current assets
37,779
9,139
6,949
4,913
-
Total assets
142,600
109,968
54,867
80,830
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
3,131
2,616
3,125
922
-
Accrued liabilities
8,143
6,410
3,625
2,828
-
Deferred revenues
1,658
1,275
9,789
0
-
Other current liabilities
1,231
659
633
149
-
Total current liabilities
19,597
14,470
18,246
4,884
-
Non-current liabilities
Deferred revenues
12,136
14,077
1,926
0
-
Total non-current liabilities
33,583
14,744
2,305
1,454
-
Total liabilities
53,180
29,214
20,551
6,338
-
Stockholders' equity
Common stock
57
32
13
13
-
Retained earnings
-311,355
-248,675
-193,397
-149,884
-
Accumulated other comprehensive income
33
10
0
-
-
Total stockholders' equity
89,420
80,754
34,316
74,492
-
Total liabilities and stockholders' equity
142,600
109,968
54,867
80,830
-